Dr. Hector Oshiro, MD

NPI: 1720180110
Total Payments
$297.35
2019 Payments
$14.81
Companies
4
Transactions
9
Medicare Patients
1,077
Medicare Billing
$154,160

Payment Breakdown by Category

Food & Beverage$297.35 (100.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $297.35 9 100.0%

Top Paying Companies

Company Total Records Latest Year
AstraZeneca Pharmaceuticals LP $120.04 1 $0 (2017)
Boehringer Ingelheim Pharmaceuticals, Inc. $92.77 3 $0 (2018)
GlaxoSmithKline, LLC. $69.73 4 $0 (2018)
Astellas Pharma US Inc $14.81 1 $0 (2019)

Payment History by Year

Year Amount Transactions Top Company
2019 $14.81 1 Astellas Pharma US Inc ($14.81)
2018 $50.79 2 Boehringer Ingelheim Pharmaceuticals, Inc. ($36.35)
2017 $231.75 6 AstraZeneca Pharmaceuticals LP ($120.04)

All Payment Transactions

9 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
01/10/2019 Astellas Pharma US Inc MYRBETRIQ (Drug) Food and Beverage In-kind items and services $14.81 General
Category: UROLOGY
10/24/2018 Boehringer Ingelheim Pharmaceuticals, Inc. SPIRIVA RESPIMAT (Drug) Food and Beverage In-kind items and services $36.35 General
Category: RESPIRATORY
04/26/2018 GlaxoSmithKline, LLC. SHINGRIX (Biological) Food and Beverage In-kind items and services $14.44 General
Category: VACCINES
11/10/2017 Boehringer Ingelheim Pharmaceuticals, Inc. STIOLTO (Drug) Food and Beverage In-kind items and services $28.21 General
Category: RESPIRATORY
10/13/2017 Boehringer Ingelheim Pharmaceuticals, Inc. STIOLTO (Drug) Food and Beverage In-kind items and services $28.21 General
Category: RESPIRATORY
10/12/2017 AstraZeneca Pharmaceuticals LP BEVESPI AEROSPHERE (Drug) Food and Beverage In-kind items and services $120.04 General
Category: Respiratory
05/20/2017 GlaxoSmithKline, LLC. ANORO (Drug) Food and Beverage In-kind items and services $19.64 General
Category: RESPIRATORY
03/24/2017 GlaxoSmithKline, LLC. ANORO (Drug) Food and Beverage In-kind items and services $17.85 General
Category: RESPIRATORY
01/12/2017 GlaxoSmithKline, LLC. ANORO (Drug) Food and Beverage In-kind items and services $17.80 General
Category: RESPIRATORY

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 3 198 382 $81,030 $31,872
2022 4 222 431 $89,985 $36,438
2021 5 306 522 $104,650 $47,781
2020 6 351 553 $93,311 $38,070
Total Patients
1,077
Total Services
1,888
Medicare Billing
$154,160
Procedure Codes
18

All Medicare Procedures & Services

18 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 92 237 $55,710 $19,818 35.6%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2023 53 53 $10,600 $6,610 62.4%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 53 92 $14,720 $5,444 37.0%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 97 258 $58,720 $21,055 35.9%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2022 69 69 $13,800 $8,832 64.0%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 44 89 $14,165 $5,469 38.6%
99443 Telephone medical discussion with physician, 21-30 minutes Office 2022 12 15 $3,300 $1,082 32.8%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 109 273 $58,990 $26,066 44.2%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2021 78 78 $15,600 $10,221 65.5%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 52 80 $12,800 $5,381 42.0%
99443 Physician telephone patient service, 21-30 minutes of medical discussion Office 2021 34 45 $9,900 $3,511 35.5%
99442 Physician telephone patient service, 11-20 minutes of medical discussion Office 2021 33 46 $7,360 $2,602 35.4%
99214 Established patient office or other outpatient, visit typically 25 minutes Office 2020 98 173 $33,221 $12,559 37.8%
99442 Physician telephone patient service, 11-20 minutes of medical discussion Office 2020 78 165 $22,300 $8,393 37.6%
99443 Physician telephone patient service, 21-30 minutes of medical discussion Office 2020 70 96 $18,440 $7,665 41.6%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2020 61 61 $12,200 $6,999 57.4%
99213 Established patient office or other outpatient visit, typically 15 minutes Office 2020 30 43 $6,100 $2,249 36.9%
93000 Routine ekg using at least 12 leads including interpretation and report Office 2020 14 15 $1,050 $203.82 19.4%

About Dr. Hector Oshiro, MD

Dr. Hector Oshiro, MD is a Infectious Disease healthcare provider based in Pawtucket, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/05/2006. The National Provider Identifier (NPI) number assigned to this provider is 1720180110.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Hector Oshiro, MD has received a total of $297.35 in payments from pharmaceutical and medical device companies, with $14.81 received in 2019. These payments were reported across 9 transactions from 4 companies. The most common payment nature is "Food and Beverage" ($297.35).

As a Medicare-enrolled provider, Oshiro has provided services to 1,077 Medicare beneficiaries, totaling 1,888 services with total Medicare billing of $154,160. Data is available for 4 years (2020–2023), covering 18 distinct procedure/service records.

Practice Information

  • Specialty Infectious Disease
  • Location Pawtucket, RI
  • Active Since 09/05/2006
  • Last Updated 07/08/2007
  • Taxonomy Code 207RI0200X
  • Entity Type Individual
  • NPI Number 1720180110

Products in Payments

  • BEVESPI AEROSPHERE (Drug) $120.04
  • STIOLTO (Drug) $56.42
  • ANORO (Drug) $55.29
  • SPIRIVA RESPIMAT (Drug) $36.35
  • MYRBETRIQ (Drug) $14.81
  • SHINGRIX (Biological) $14.44

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.